ID

41210

Description

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01394640

Link

https://clinicaltrials.gov/show/NCT01394640

Keywords

Versions (1)
  1. 7/14/20 7/14/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 14, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT01394640

English

Eligibility Lymphoma NCT01394640

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01394640
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
oncologic and hematologic patient with the plan of receiving the a (h1n1) vaccine
Description

Patient Oncologic Hematologic | influenza virus vaccine, H1N1 Planned

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0205478
UMLS CUI [1,3]
C0205488
UMLS CUI [2,1]
C2722215
UMLS CUI [2,2]
C1301732
control group: a silent history for oncologic and hematologic diseases; planned of receiving the a (h1n1) vaccine
Description

Control Group | Oncologic disorders | Hematological Disease | influenza virus vaccine, H1N1 Planned

Data type

boolean

Alias
UMLS CUI [1]
C0009932
UMLS CUI [2]
C3853943
UMLS CUI [3]
C0018939
UMLS CUI [4,1]
C2722215
UMLS CUI [4,2]
C1301732
written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
infusion of human immunoglobulin ongoing or within prior 30 days
Description

Immune Globulin Infusion

Data type

boolean

Alias
UMLS CUI [1,1]
C0358321
UMLS CUI [1,2]
C0574032
therapy with monoclonal or polyclonal antibodies ongoing or within prior 30 days
Description

Monoclonal Antibody Therapy | Polyclonal antibody

Data type

boolean

Alias
UMLS CUI [1]
C0279694
UMLS CUI [2]
C0312586
therapy with il-1 or il-2 or ifn-gamma ongoing or within prior 30 days
Description

IL-1 therapy | Interleukin-2 therapy | Gamma interferon therapy

Data type

boolean

Alias
UMLS CUI [1]
C0860386
UMLS CUI [2]
C0199975
UMLS CUI [3]
C0854623
autologous pbsct less than 1 month or allogeneic pbsct less than 6 months
Description

Autologous peripheral blood stem cell transplant | Allogeneic peripheral blood stem cell transplant

Data type

boolean

Alias
UMLS CUI [1]
C1960579
UMLS CUI [2]
C1960580
pregnancy or lactation
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
type i hypersensitivity
Description

Hypersensitivity type

Data type

boolean

Alias
UMLS CUI [1]
C0441750
ongoing anticoagulant therapy or platelets < 50000/ul
Description

Anticoagulant therapy | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0150457
UMLS CUI [2]
C0032181
Back to the top of the page

Similar models

Eligibility Lymphoma NCT01394640

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01394640
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
Patient Oncologic Hematologic | influenza virus vaccine, H1N1 Planned
Item
oncologic and hematologic patient with the plan of receiving the a (h1n1) vaccine
boolean
C0030705 (UMLS CUI [1,1])
C0205478 (UMLS CUI [1,2])
C0205488 (UMLS CUI [1,3])
C2722215 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
Control Group | Oncologic disorders | Hematological Disease | influenza virus vaccine, H1N1 Planned
Item
control group: a silent history for oncologic and hematologic diseases; planned of receiving the a (h1n1) vaccine
boolean
C0009932 (UMLS CUI [1])
C3853943 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C2722215 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Immune Globulin Infusion
Item
infusion of human immunoglobulin ongoing or within prior 30 days
boolean
C0358321 (UMLS CUI [1,1])
C0574032 (UMLS CUI [1,2])
Monoclonal Antibody Therapy | Polyclonal antibody
Item
therapy with monoclonal or polyclonal antibodies ongoing or within prior 30 days
boolean
C0279694 (UMLS CUI [1])
C0312586 (UMLS CUI [2])
IL-1 therapy | Interleukin-2 therapy | Gamma interferon therapy
Item
therapy with il-1 or il-2 or ifn-gamma ongoing or within prior 30 days
boolean
C0860386 (UMLS CUI [1])
C0199975 (UMLS CUI [2])
C0854623 (UMLS CUI [3])
Autologous peripheral blood stem cell transplant | Allogeneic peripheral blood stem cell transplant
Item
autologous pbsct less than 1 month or allogeneic pbsct less than 6 months
boolean
C1960579 (UMLS CUI [1])
C1960580 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity type
Item
type i hypersensitivity
boolean
C0441750 (UMLS CUI [1])
Anticoagulant therapy | Platelet Count measurement
Item
ongoing anticoagulant therapy or platelets < 50000/ul
boolean
C0150457 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial